Psoriatic Arthritis Impact of Disease (PsAID12) Was Provisionally Endorsed at Omeract 2018 As Core Instrument to Measure Psoriatic Arthritis-Specific Health-Related Quality of Life in Randomized Controlled Trials and Longitudinal Observational Studies
Publication
, Conference
Holland, R; Christensen, R; Goel, N; Hoejgaard, P; Tillett, W; Gossec, L; de Wit, M; McHugh, N; Mease, PJ; Shea, B; Leung, YY; Gladman, DD ...
Published in: ARTHRITIS & RHEUMATOLOGY
September 1, 2018
Duke Scholars
Published In
ARTHRITIS & RHEUMATOLOGY
EISSN
2326-5205
ISSN
2326-5191
Publication Date
September 1, 2018
Volume
70
Publisher
WILEY
Related Subject Headings
- 3204 Immunology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Holland, R., Christensen, R., Goel, N., Hoejgaard, P., Tillett, W., Gossec, L., … Orbai, A.-M. (2018). Psoriatic Arthritis Impact of Disease (PsAID12) Was Provisionally Endorsed at Omeract 2018 As Core Instrument to Measure Psoriatic Arthritis-Specific Health-Related Quality of Life in Randomized Controlled Trials and Longitudinal Observational Studies. In ARTHRITIS & RHEUMATOLOGY (Vol. 70). WILEY.
Holland, Richard, Robin Christensen, Niti Goel, Pil Hoejgaard, William Tillett, Laure Gossec, Maarten de Wit, et al. “Psoriatic Arthritis Impact of Disease (PsAID12) Was Provisionally Endorsed at Omeract 2018 As Core Instrument to Measure Psoriatic Arthritis-Specific Health-Related Quality of Life in Randomized Controlled Trials and Longitudinal Observational Studies.” In ARTHRITIS & RHEUMATOLOGY, Vol. 70. WILEY, 2018.
Holland R, Christensen R, Goel N, Hoejgaard P, Tillett W, Gossec L, et al. Psoriatic Arthritis Impact of Disease (PsAID12) Was Provisionally Endorsed at Omeract 2018 As Core Instrument to Measure Psoriatic Arthritis-Specific Health-Related Quality of Life in Randomized Controlled Trials and Longitudinal Observational Studies. In: ARTHRITIS & RHEUMATOLOGY. WILEY; 2018.
Holland, Richard, et al. “Psoriatic Arthritis Impact of Disease (PsAID12) Was Provisionally Endorsed at Omeract 2018 As Core Instrument to Measure Psoriatic Arthritis-Specific Health-Related Quality of Life in Randomized Controlled Trials and Longitudinal Observational Studies.” ARTHRITIS & RHEUMATOLOGY, vol. 70, WILEY, 2018.
Holland R, Christensen R, Goel N, Hoejgaard P, Tillett W, Gossec L, de Wit M, McHugh N, Mease PJ, Shea B, Leung YY, Gladman DD, Lindsay C, Coates LC, Ogdie A, Strand V, Fallon L, Birt J, Duffin KC, FitzGerald O, Tugwell P, Beaton D, Orbai A-M. Psoriatic Arthritis Impact of Disease (PsAID12) Was Provisionally Endorsed at Omeract 2018 As Core Instrument to Measure Psoriatic Arthritis-Specific Health-Related Quality of Life in Randomized Controlled Trials and Longitudinal Observational Studies. ARTHRITIS & RHEUMATOLOGY. WILEY; 2018.
Published In
ARTHRITIS & RHEUMATOLOGY
EISSN
2326-5205
ISSN
2326-5191
Publication Date
September 1, 2018
Volume
70
Publisher
WILEY
Related Subject Headings
- 3204 Immunology
- 3202 Clinical sciences